{"database": "lobbying", "table": "lobbying_activities", "rows": [[1930067, "9e9b562f-9e96-419f-8d1c-4fdbdca30827", "Q4", "EMERGENT BIOSOLUTIONS INC.", 304931, "EMERGENT BIOSOLUTIONS INC", 2016, "fourth_quarter", "DIS", "Department of Labor, Health and Human Services, Education and Related Agencies Appropriations Act, 2017- provisions related to development, acquisition and stockpiling of biodefense vaccines.\nDepartment of Homeland Security Appropriations Act, 2017 - provisions related to development, acquisition and stockpiling of biodefense vaccines.\nDepartment of Defense Appropriations 2017 - provisions related to chemical decontamination and Ebola response preparedness\nNational Defense Authorization Act for Fiscal  Year 2017 - issues related to the National Biodefense Plan and chemical decontamination\nH.R. 1300 - - First Responder Anthrax Preparedness Act -   directs the Secretary of Homeland Security to make anthrax vaccines and antimicrobials available to emergency response providers.\nS 1915 - First Responder Anthrax Preparedness Act -   directs the Secretary of Homeland Security to make anthrax vaccines and antimicrobials available to emergency response providers.\nH.R. 3299 - The Strengthening Public Health Emergency Response Act of 2015\nS 2055 - Medical Countermeasure Innovation Act of 2015\nH.R. 34 - 21st Century Cures", "HOUSE OF REPRESENTATIVES,SENATE", null, 420000, 0, 0, "2017-01-21T17:32:13-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1930067"], "units": {}, "query_ms": 34.37289805151522, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}